Re: Cabazitaxel versus Docetaxel as First-Line Therapy for Patients with Metastatic Castration-Resistant Prostate Cancer: A Randomized Phase III Trial-FIRSTANA

Samir S. Taneja

    Research output: Contribution to journalComment/debate

    Original languageEnglish (US)
    Pages (from-to)893-894
    Number of pages2
    JournalThe Journal of urology
    Volume199
    Issue number4
    DOIs
    StatePublished - Apr 1 2018

    ASJC Scopus subject areas

    • Urology

    Cite this